All Stories

  1. Pharmacologic Characterization of AMG8379, a Potent and Selective Small Molecule Sulfonamide Antagonist of the Voltage-Gated Sodium Channel NaV1.7

    Article • Journal of Pharmacology and Experimental Therapeutics, May 2017, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Bryan Moyer

  2. Evaluation of recombinant monoclonal antibody SVmab1 binding to NaV1.7 target sequences and block of human NaV1.7 currents

    Article • F1000Research, November 2016, Faculty of 1000, Ltd.

    Bryan Moyer